Inscripta Stock

inscripta.comHealthcareFounded: 2015Funding to Date: $459.69MM

Inscripta is the developer of a benchtop platform for scalable digital genome engineering consisting of an instrument, consumables, software, and assays, that offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.

Register for Details

For more details on financing and valuation for Inscripta, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Inscripta.

Register Today

Inscripta investors also invested in these private companies

Team

Management Team

Michael Graige Ph.D
Chief Technology Officer
Andrew Garst Ph.D
Co-Founder & Principal Scientist
Kevin Ness Ph.D
Chief Executive Officer
Jason Gammack
Chief Commercial Officer

Board Members

Bryan Roberts Ph.D
Venrock
Roger Wyse Ph.D
Spruce Capital Partners
Eric Moessinger
NanoDimension
John Stuelpnagel

Other companies like Inscripta in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

The Finnish language technology company Inscripta Oy has raised a total of 700K in funding for the further development of its self-developed speech recognition technology and final solutions. Having begun operations in 2016, Inscripta is a 16-person software company that has developed a comprehensive and versatile end-to-end speech recognition solution for healthcare organizations and other […]
Inscripta, Inc., a Boulder, CO-based digital genome engineering company, closed a $150m Series E financing
In these waning days of the second decade of the twenty-first century, technologists and investors are beginning to lay the foundations for new, truly transformational technologies that have the potential to reshape entire industries and rewrite the rules of human understanding. It may sound lofty,